00:01
In order to answer this question, talk about cholesterol synthesis.
00:03
It is rachel is studying cholesterol in mice.
00:06
Some mice had a mutation in the cholesterol, a regulatory element binding protein that is normally active when cholesterol levels are low in the cell.
00:15
Remember that when you have low levels of cholesterol in the liver, then this is going to stimulate the de novo cholesterol synthesis.
00:30
Because remember that you can acquire cholesterol by this process, cholesterol synthesis and also you can acquire cholesterol by from the diet.
00:39
So if you have or you're ingesting low levels of cholesterol, then this is going to stimulate that in no cholesterol synthesis in order to produce, okay, inside of your body or in the liver specifically more cholesterol, okay? so it says this mutation can no longer bind to the gene promoter for cholesterol synthesis pathway enzyme hmgcoa reductase.
01:00
What will happen to hmgcoa reductase levels? so this sterogorogulatory element binding protein is a transcription factor, and this transcription factor normally binds to the dna specifically to one gene, and this gene is the gene for the enzyme that is called hmg foa reductics...